Sound Pharmaceuticals, Inc.
PrivateLast Round
Grant
May 11, 2022
Total Funding Raised
$27.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sound Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Grant round in May 2022.
Sound Pharmaceuticals, Inc. is a biotechnology company that develops novel therapeutics for the treatment of hearing loss and neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sound Pharmaceuticals, Inc. Comparables
Compare Sound Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Otologic Pharmaceutics | 87% | |
| Gateway Biotechnology, Inc. | 87% | |
| Audion Therapeutics | 84% |
For institutional investors. Book with your work email.
Sound Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 11, 2022 | ||||
| Grant | Apr 6, 2021 | ||||
| Series B | Jun 6, 2018 | ||||
| Grant | Sep 29, 2017 | ||||
| Series A | Sep 16, 2016 | ||||
Grant | Jul 21, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sound Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Office of Naval Research | Grant |
| Cystic Fibrosis Foundation | Grant |
| National Center for Advancing Translational Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 66% MoM.
- Jun 7, 2026
Grew 16% QoQ, from 19 to 22 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 19, 2026
Sound Pharmaceuticals, Inc. conducts ongoing clinical development of investigational oral drug SPI-1005 for Ménière's disease, supported by Phase 3 trial data showing improved hearing thresholds and speech understanding.
For institutional investors. Book with your work email.
Sound Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sound Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Sound Pharmaceuticals, Inc. a public or private company?
Sound Pharmaceuticals, Inc. is a private company.
What is the current stock price of Sound Pharmaceuticals, Inc.?
Sound Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Sound Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sound Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Sound Pharmaceuticals, Inc. is not publicly available.
Can I buy Sound Pharmaceuticals, Inc. stock?
Sound Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sound Pharmaceuticals, Inc.'s last funding round?
Sound Pharmaceuticals, Inc.'s most recent funding round was Grant on May 11, 2022.
Who are the main investors in Sound Pharmaceuticals, Inc.?
Key investors in Sound Pharmaceuticals, Inc. include Office of Naval Research, Cystic Fibrosis Foundation, National Center for Advancing Translational Sciences.
Will Sound Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Sound Pharmaceuticals, Inc..
How can I track Sound Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Sound Pharmaceuticals, Inc.'s shares on secondary markets.